Stockreport

NeuroSense Granted Brazilian Patent Covering PrimeC Composition [Yahoo! Finance]

NeuroSense Therapeutics Ltd. - Ordinary Shares  (NRSN) 
PDF CAMBRIDGE, Mass. April 6, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"), a late-clinical stage biotechnology company [Read more]